Free Letter - District Court of Delaware - Delaware

2 Case 1 :04-cv—00171-GIVIS Document 143 Filed 08/15/2006 Page 1 of 1
@®??i.hi@i-L`i .... in QQGE sr .. isi? .... il? Lie?
. Arronieavs ar Law
eliminates, er
lite Nemours Building
EDO? Norte Grange St.
PO. Box 2207
Wilmington, DE l9S99
rst; (sca; sas sun
Francis DiGiovarm% gw, {EQ2, 558 551,,
Famer wss; »rwt~.·.¤eil¤.wm
rs:. (302} 8886316
Fax (302) 658-5614
EMAIL [email protected]
anew ro Wilmington Ofuca
August 15, 2006
VIA ECF AND HAND DELIVERY
The Honorable Kent A. Jordan
United States District Court
District of Delaware
844 North King Street
Wilmington, DE 19801
Re: Glaxo Group Limited v. T em Pharma. USA, Inc., ei. al, Civ. No. 04-—l7l-KA]
Dear Judge Jordan:
Enclosed is a Stipulation and Order regarding the issue of the expiration ofthe 30~1nonth
. stay of FDA approval that was the subject Glaxo’s letter to the Court dated July 26, 2006, and
the teleconference held on July 27, 2006. The Stipulation and Order has been executed by the
parties. The parties believe that the Stipuiation and Order obviates the need for the
teleconference scheduled for 4:30 pin. today, and, as continned with Chambers earlier today, the
teleconference has been taken off the Court’s schedule.
Respectfully submitted,
-·--···‘‘‘‘‘ ·- ‘r’;§
·rl l‘ re·i rdridr?\rn
Francis DiGiovanni
FD:
Enclosure
cc: Clerk ofthe Court (by ECF)
Josy W. Ingersoll, Esquire (by hand)
Brian P. Murphy, Esquire (by email)
Marla D. Schuman, Esquire (by e-mail)
4S2009_l
ii'¥lLt»é}§%éG?Gi~l, QE ii€§i»S§·§lE¤it’5T{3?~l, QQ ggg ;;;~;;gLgg_ gg;

Case 1:04-cv-00171-GMS

Document 143

Filed 08/15/2006

Page 1 of 1